BSTRACT
Background: Postprandial lipemia (PPL) is an independent predictor of early
atherosclerosis and coronary artery disease. It is defined as a postprandial
triglyceride (TG) level >80% higher than the fasting level. Brachial arterial reactivity
(BAR) is used to identify early-phase atherosclerosis. Data concerning
whether orlistat improves PPL and endothelial function are lacking.